NUPATHE INC. 4
4 · NUPATHE INC. · Filed Feb 25, 2014
Insider Transaction Report
Form 4
NUPATHE INC.PATH
Datin James A
Director
Transactions
- Disposition from Tender
Common Stock
2014-02-21$6.80/sh−20,620$140,216→ 0 total
Footnotes (1)
- [F1]Disposed upon the consummation of the merger contemplated by the Agreement and Plan of Merger, dated January 17, 2014, among the issuer, Teva Pharmaceutical Industries Ltd. and Train Merger Sub, Inc., in exchange for $3.65 per share, plus contractual rights to receive up to an additional $3.15 in contingent cash consideration payments per share.